Literature DB >> 24793468

Association of HLA-DR/DQ polymorphisms with Guillain-Barré syndrome in Tunisian patients.

Najiba Fekih-Mrissa1, Meriem Mrad2, Anis Riahi3, Aicha Sayeh2, Jamel Zaouali3, Nasreddine Gritli4, Ridha Mrissa3.   

Abstract

UNLABELLED: Human leukocyte antigen (HLA) alleles have been implicated in many autoimmune diseases. The aim of this study is to assess whether HLA-DR/DQ alleles confer susceptibility to Guillain-Barré syndrome (GBS) in a Tunisian population.
METHODS: The HLA-DR/DQ genotyping was performed using polymerase chain reaction sequence-specific primers (PCR-SSP) in 38 patients with GBS and 100 healthy Tunisian control subjects.
RESULTS: GBS in Tunisian patients was found to be associated with the following alleles with these relative patient versus control frequencies (pc denotes Bonferroni corrected probability values): DRB1*13 (23.68% vs. 9.0%; pc=0.01), followed by DRB1*14 (22.36% vs.5.5%; pc<10(-3)). Two haplotypes, DRB1*14/DQB1*05 and DRB1*13/DQB1*03, were found to be associated with susceptibility to GBS. However DRB1*07/DQB1*02 and DRB1*03/DQB1*02 haplotypes were more frequently observed in controls than in patients (11.5% vs.7.9%; pc=0.007 and 23% vs. 5.26%; pc<10(-3) respectively). These haplotypes seem to confer protection against the disease.
CONCLUSION: Our data demonstrated a new GBS predisposition associated with HLA-DRB1*14 and DRB1*13. Theses alleles could be predisposing genetic factors for GBS in the Tunisian population.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Guillain–Barré syndrome (GBS); HLA; Neuroimmunology; Neuropathy

Mesh:

Substances:

Year:  2014        PMID: 24793468     DOI: 10.1016/j.clineuro.2014.03.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

1.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

Review 3.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

Review 4.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 5.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

6.  Multilocus sequence typing confirms wild birds as the source of a Campylobacter outbreak associated with the consumption of raw peas.

Authors:  Patrick S L Kwan; Catherine Xavier; Monica Santovenia; Janet Pruckler; Steven Stroika; Kevin Joyce; Tracie Gardner; Patricia I Fields; Joe McLaughlin; Robert V Tauxe; Collette Fitzgerald
Journal:  Appl Environ Microbiol       Date:  2014-08       Impact factor: 4.792

Review 7.  Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Peng-Peng Jin; Li-Li Sun; Bo-Jun Ding; Na Qin; Bin Zhou; Feng Xia; Li Li; Li-Juan Liu; Xue-Dong Liu; Gang Zhao; Wen Wang; Yan-Chun Deng; Shuang-Xing Hou
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

8.  Association between human leukocyte antigen-DR and demylinating Guillain-Barre syndrome.

Authors:  Zaki N Hasan; Haider H Zalzala; Hyam R Mohammedsalih; Batool M Mahdi; Laheeb A Abid; Zena N Shakir; Maithem J Fadhel
Journal:  Neurosciences (Riyadh)       Date:  2014-10       Impact factor: 0.906

9.  Young woman with Guillain-Barré syndrome and cervical transverse myelitis-A new GBS variant, not coincidence.

Authors:  Jenna Gharzeddine; Brian Renner; Natalie Wassall; Kristen Tran; Antonio Liu
Journal:  Clin Case Rep       Date:  2020-04-21

Review 10.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.